Clinical and serological manifestations | APS patients (n = 130) | All controls (n = 58) | Healthy controls N = 40 | Sepsis control n = 18 |
---|---|---|---|---|
Age (years ± SD) | 43.8 ± 13.2 | 37.7 ± 10.7 | 37 ± 11.7 | 39 ± 9 |
Gender (Female) | 79.2% | 66% | 80% | 30% |
Time from diagnosis (years ± SD) | 8.3 ± 7.4 | NA | ||
Secondary APS | 51.5% | NA | ||
Arterial thrombosis | 47.7% | NA | ||
CNS manifestations | 35.4% | NA | ||
Venous thrombosis | 59.2% | NA | ||
Pregnancy morbidity | 29.2% | NA | ||
(LAC) positivity | 84.0% | NA | ||
Triple positive (aCL + aβ2GP1 + LAC) | 55.0% | NA |